https://pubmed.ncbi.nlm.nih.gov/33159365/
"I'd say a Feb 2021 journal published phase 2 trial with 40% remission rate on 10 patients who had/are in really really bad shape isn't cherry-picking."
The potential of a plethora of mountains of research combined with other drugs that has completed similar buyouts is what is really driving growth from smart investors. It doesn't go into full detail because you need full access to view it. (ie. buying the text) the limitation of this trial is due to the phase it is in. I've read the full test and one of the patients (with 3+ failed attempts at remission) would have gone into full remission, had the trial continued past it's scheduled final date.
- From reddit
I'm predicting and looking forward to a slight raise in SP today before the weekend.
https://pubmed.ncbi.nlm.nih.gov/33159365/"I'd say a Feb 2021...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.010(0.81%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $381.6K | 320.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 2171 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
-0.010 ( 5.54 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 48407 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |